Palisade Bio Stock (NASDAQ: PALI) stock price, news, charts, stock research, profile.
You can purchase shares of Palisade Bio (NASDAQ:PALI) through any online brokerage.
Other companies in Palisade Bio’s space includes: Tharimmune (NASDAQ:THAR), Entero Therapeutics (NASDAQ:ENTO), Synaptogenix (NASDAQ:SNPX), Quoin Pharmaceuticals (NASDAQ:QNRX) and NuCana (NASDAQ:NCNA).
Palisade Bio has a consensus price target of $19.25.
The stock price for Palisade Bio (NASDAQ: PALI) is $2.59 last updated October 31, 2024 at 5:09 PM EDT.
There are no upcoming dividends for Palisade Bio.
Palisade Bio’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Palisade Bio.
Palisade Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.